Breast magnetic resonance imaging (MRI) is widely regarded as the most sensitive imaging modality for diagnosing breast diseases, particularly in the detection of malignant lesions [1]. Dynamic contrast-enhanced breast MRI (DCE-MRI), with its high sensitivity, has emerged as a critical tool in problem-solving, early detection, and evaluation of breast cancer and other pathologies [2,3]. Although conventional FDB-MRI protocols are considered the gold standard for screening high-risk individuals a…